Cargando…
Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057847/ https://www.ncbi.nlm.nih.gov/pubmed/32180732 http://dx.doi.org/10.3389/fphar.2020.00201 |
_version_ | 1783503747379363840 |
---|---|
author | Ye, Chuantao Wang, Dan Liu, He Ma, Hongwei Dong, Yangchao Yao, Min Wang, Yuan Zhang, Hui Zhang, Liang Cheng, Linfeng Xu, Zhikai Lei, Yingfeng Zhang, Fanglin Ye, Wei |
author_facet | Ye, Chuantao Wang, Dan Liu, He Ma, Hongwei Dong, Yangchao Yao, Min Wang, Yuan Zhang, Hui Zhang, Liang Cheng, Linfeng Xu, Zhikai Lei, Yingfeng Zhang, Fanglin Ye, Wei |
author_sort | Ye, Chuantao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7057847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70578472020-03-16 Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection Ye, Chuantao Wang, Dan Liu, He Ma, Hongwei Dong, Yangchao Yao, Min Wang, Yuan Zhang, Hui Zhang, Liang Cheng, Linfeng Xu, Zhikai Lei, Yingfeng Zhang, Fanglin Ye, Wei Front Pharmacol Pharmacology Frontiers Media S.A. 2020-02-27 /pmc/articles/PMC7057847/ /pubmed/32180732 http://dx.doi.org/10.3389/fphar.2020.00201 Text en Copyright © 2020 Ye, Wang, Liu, Ma, Dong, Yao, Wang, Zhang, Zhang, Cheng, Xu, Lei, Zhang and Ye. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Ye, Chuantao Wang, Dan Liu, He Ma, Hongwei Dong, Yangchao Yao, Min Wang, Yuan Zhang, Hui Zhang, Liang Cheng, Linfeng Xu, Zhikai Lei, Yingfeng Zhang, Fanglin Ye, Wei Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection |
title | Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection |
title_full | Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection |
title_fullStr | Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection |
title_full_unstemmed | Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection |
title_short | Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection |
title_sort | corrigendum: an improved enzyme-linked focus formation assay revealed baloxavir acid as a potential antiviral therapeutic against hantavirus infection |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057847/ https://www.ncbi.nlm.nih.gov/pubmed/32180732 http://dx.doi.org/10.3389/fphar.2020.00201 |
work_keys_str_mv | AT yechuantao corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT wangdan corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT liuhe corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT mahongwei corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT dongyangchao corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT yaomin corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT wangyuan corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT zhanghui corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT zhangliang corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT chenglinfeng corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT xuzhikai corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT leiyingfeng corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT zhangfanglin corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection AT yewei corrigendumanimprovedenzymelinkedfocusformationassayrevealedbaloxaviracidasapotentialantiviraltherapeuticagainsthantavirusinfection |